Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Piper

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Pharmacotherapy|May 26, 2017
A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert ProgramBrian J Piper, Clare E Desrosiers, Harriet C Fisher, et al.
Plos One|August 18, 2025
Declines and pronounced state-level variation in clozapine use among Medicare patientsLuke R Cavanah, Maria Y Tian, Jessica L Goldhirsh, et al.
Medicine|March 17, 2021
Application of medical cannabis in unstable angina and coronary artery disease: A case reportBrian L Shaffer, Garrison M Davis, Marc A Incitti, et al.
Research in Social & Administrative Pharmacy : RSAP|March 9, 2023
Reductions and pronounced regional differences in morphine distribution in the United StatesMegan E Dowd, E Jessica Tang, Kurlya T Yan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 5, 2007
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopramBrian J Piper, Joseph B Fraiman, Cullen B Owens, et al.
Frontiers in Psychiatry|March 20, 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreeningLuke R Cavanah, Parita K Ray, Jessica L Goldhirsh, et al.
BMJ Open|March 7, 2024
State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USAJay P Solgama, Edward Liu, Mellar Davis, et al.
Peerj|December 12, 2019
Dynamic changes in prescription opioids from 2006 to 2017 in TexasEbuwa O Ighodaro, Kenneth L McCall, Daniel Y Chung, et al.
Pharmacopsychiatry|July 31, 2024
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USAGarrett D Alexander, Luke R Cavanah, Jessica L Goldhirsh, et al.
Brain Research|December 9, 2008
Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonistDominik K Biezonski, Andrea B Courtemanche, Sang B Hong, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Pharmacotherapy|May 26, 2017
A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert ProgramBrian J Piper, Clare E Desrosiers, Harriet C Fisher, et al.
Plos One|August 18, 2025
Declines and pronounced state-level variation in clozapine use among Medicare patientsLuke R Cavanah, Maria Y Tian, Jessica L Goldhirsh, et al.
Medicine|March 17, 2021
Application of medical cannabis in unstable angina and coronary artery disease: A case reportBrian L Shaffer, Garrison M Davis, Marc A Incitti, et al.
Research in Social & Administrative Pharmacy : RSAP|March 9, 2023
Reductions and pronounced regional differences in morphine distribution in the United StatesMegan E Dowd, E Jessica Tang, Kurlya T Yan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 5, 2007
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopramBrian J Piper, Joseph B Fraiman, Cullen B Owens, et al.
Frontiers in Psychiatry|March 20, 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreeningLuke R Cavanah, Parita K Ray, Jessica L Goldhirsh, et al.
BMJ Open|March 7, 2024
State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USAJay P Solgama, Edward Liu, Mellar Davis, et al.
Peerj|December 12, 2019
Dynamic changes in prescription opioids from 2006 to 2017 in TexasEbuwa O Ighodaro, Kenneth L McCall, Daniel Y Chung, et al.
Pharmacopsychiatry|July 31, 2024
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USAGarrett D Alexander, Luke R Cavanah, Jessica L Goldhirsh, et al.
Brain Research|December 9, 2008
Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonistDominik K Biezonski, Andrea B Courtemanche, Sang B Hong, et al.
Pageof 14